eXoZymes (Nasdaq: EXOZ)

eXoZymes has developed a next gen biomanufacturing platform capable of producing highly valuable natural products. As a historic first, this cell-free platform offers the bioengineering tools and design-control to run nature’s own natural enzyme pathways without living cells. AI is used to genetically optimize the cell-free enzymes - called exozymes - to thrive in a bioreactor outside the cell.